Be Prepared to Treat and Prevent VTE Due to Cancer

June 2020

Recent guideline changes will raise questions about how to treat and prevent cancer-associated venous thromboembolism (VTE).

Be prepared to manage these patients...and help avoid errors.

Treatment. For years, we've been using a low-molecular-weight heparin (LMWH), such as enoxaparin, for most patients with cancer.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote